GAS5

ncRNA information

ncRNA name

GAS5

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Lung Adenocarcinoma

Cancer site

Lung

Treatment information

Treatment type

Chemotherapy

Drug

Gefitinib

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Down

Number of patients

72

Male patients

37

Female patients

35

Age range and number

Not available

Research information

PMID

Description

GAS5 treatment enhances gefitinib sensitivity in vitro.

Tissue resource

paired cancerous and matched adjacent noncancerous lung tissues

human lung adenocarcinoma cell lines A549

human lung adenocarcinoma cell lines H1299

human lung adenocarcinoma cell lines H1975

human lung adenocarcinoma cell lines HCC827

human lung adenocarcinoma cell lines HBE

Experiment

qRT-PCR,Western blot


Institute

First Hospital of China Medical University

the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences

Country

China

Continent

Asia